For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Search Posts
Blog
Supreme Court Concocts New “Rational (Tax) Basis” Test in Upholding Health Law
In a move that seems to have surprised many observers, the Supreme Court today upheld nearly all of the Patient Protection and Affordable Care Act…
Blog
Obamacare Upheld, 5-to-4: A Perverse Decision That Undermines Political Accountability
Today, in a really perverse ruling, the Supreme Court upheld Obamacare's individual mandate as a tax in a 5-to-4 decision, even though Obamacare's supporters…
Blog
Quick Thoughts on the Health Care Ruling
The Supreme Court upheld the health care bill, as you've no doubt heard by now. Over at the Daily Caller, I offer a few quick…
Daily Caller
Three Quick Thoughts on the Health Care Ruling
The Supreme Court has upheld the health care law’s insurance mandate, to the surprise of many. This surprise sparked a few quick thoughts about the…
News Release
Supreme Court Concocts “Rational Tax Test” in Health Ruling
Washington, D.C., June 28, 2012 – Statement by CEI Senior Fellow Gregory Conko: In enacting the health care individual purchase mandate, Congress…
Real Clear Markets
Global Governments’ Growing Embrace of Big Pharma
As the pharmaceutical industry wrestles with multiple existential threats-from price controls to patent cliffs to dwindling pipelines-calls are growing for deeper government-industry cooperation. As private…